参考文献/References:
[1] Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.National Diabetes Data Group[J].Diabetes,1979,28(12):1039-1057.DOI:10.2337/diab.28.12.1039.
[2] Insel RA,Dunne JL,Atkinson MA,et al.Staging presymptomatic type 1 diabetes:a scientific statement of JDRF,the Endocrine Society,and the American Diabetes Association[J].Diabetes Care,2015,38(10):1964-1974.DOI:10.2337/dc15-1419.
[3] DiMeglio LA,Evans-Molina C,Oram RA.Type 1 diabetes[J].Lancet,2018,391(10138):2449-2462.DOI:10.1016/S0140-6736(18)31320-5.
[4] 黄干,杨涛,刘煜,等.中国胰岛自身抗体检测标准化计划报告:检测方法调查及准确性评估[J].中华糖尿病杂志,2016,8(12):723-728.DOI:10.3760/cma.j.issn.1674.5809.2016.12.005.
[5] 陈恒,沈敏,戴皓,等.锌转运体8自身抗体电化学发光法的建立与应用[J].中华糖尿病杂志,2020,12(8):613-618.DOI:10.3760/cma.j.cn115791-20200429-00255.
[6] Gu Y,Jia X,Vartak T,et al.Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes[J].Diabetologia,2021,64(9):2052-2060.DOI:10.1007/s00125-021-05492-6.
[7] Mallone R,Martinuzzi E,Blancou P,et al.CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes[J].Diabetes,2007,56(3):613-621.DOI:10.2337/db06-1419.
[8] Pociot F,Lernmark A.Genetic risk factors for type 1 diabetes[J].Lancet,2016,387(10035):2331-2339.DOI:10.1016/S0140-6736(16)30582-7.
[9] Luo S,Lin J,Xie Z,et al.HLA genetic discrepancy between latent autoimmune diabetes in adults and type 1 diabetes:LADA China study No.6[J].J Clin Endocrinol Metab,2016,101(4):1693-1700.DOI:10.1210/jc.2015-3771.
[10] Zhu M,Xu K,Chen Y,et al.Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals:based on a two-stage genome-wide association study[J].Diabetes Care,2019,42(8):1414-1421.DOI:10.2337/dc18-2023.
[11] Steffes MW,Sibley S,Jackson M,et al.Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial[J].Diabetes Care,2003,26(3):832-836.DOI:10.2337/diacare.26.3.832.
[12] Ludvigsson J,Carlsson A,Forsander G,et al.C-peptide in the classification of diabetes in children and adolescents[J].Pediatr Diabetes,2012,13(1):45-50.DOI:10.1111/j.1399-5448.2011.00807.x.
[13] Jones AG,Hattersley AT.The clinical utility of C-peptide measurement in the care of patients with diabetes[J].Diabet Med,2013,30(7):803-817.DOI:10.1111/dme.12159.
[14] Shields BM,Peters JL,Cooper C,et al.Can clinical features be used to differentiate type 1 from type 2 diabetes? a systematic review of the literature[J].BMJ Open,2015,5(11):e9088.DOI:10.1136/bmjopen-2015-009088.
[15] Cho MJ,Kim MS,Kim CJ,et al.Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents[J].Ann Pediatr Endocrinol Metab,2014,19(2):80-85.DOI:10.6065/apem.2014.19.2.80.
[16] 陈双,付麒,顾愹,等.1型糖尿病临床诊断模型的建立[J].中华糖尿病杂志,2016,8(10):598-602.DOI:10.3760/cma.j.issn.1674-5809.2016.10.006.
[17] Diabetes Prevention Trial--Type 1 Diabetes Study Group.Effects of insulin in relatives of patients with type 1 diabetes mellitus[J].N Engl J Med,2002,346(22):1685-1691.DOI:10.1056/NEJMoa012350.
[18] Skyler JS,Krischer JP,Wolfsdorf J,et al.Effects of oral insulin in relatives of patients with type 1 diabetes:the diabetes prevention trial--type 1[J].Diabetes Care,2005,28(5):1068-1076.DOI:10.2337/diacare.28.5.1068.
[19] Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group.Krischer JP,Schatz DA,Bundy B,et al.Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes:a randomized clinical trial[J].JAMA,2017,318(19):1891-1902.DOI:10.1001/jama.2017.17070.
[20] Alhadj AM,Liu YF,Arif S,et al.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes[J].Sci Transl Med,2017,9(402).DOI:10.1126/scitranslmed.aaf7779.
[21] Rodriguez-Fernandez S,Almenara-Fuentes L,Perna-Barrull D,et al.A century later,still fighting back:antigen-specific immunotherapies for type 1 diabetes[J].Immunol Cell Biol,2021,99(5):461-474.DOI:10.1111/imcb.12439.
[22] Pescovitz MD,Greenbaum CJ,Bundy B,et al.B-lymphocyte depletion with rituximab and β-cell function:two-year results[J].Diabetes Care,2014,37(2):453-459.DOI:10.2337/dc13-0626.
[23] Orban T,Bundy B,Becker DJ,et al.Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes:follow-up 1 year after cessation of treatment[J].Diabetes Care,2014,37(4):1069-1075.DOI:10.2337/dc13-0604.
[24] Herold KC,Bundy BN,Long SA,et al.An anti-CD3 antibody,teplizumab,in relatives at risk for type 1 diabetes[J].N Engl J Med,2019,381(7):603-613.DOI:10.1056/NEJMoa1902226.
[25] Keymeulen B,van Maurik A,Inman D,et al.A randomised,single-blind,placebo-controlled,dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes[J].Diabetologia,2021,64(2):313-324.DOI:10.1007/s00125-020-05317-y.
[26] Rigby MR,Harris KM,Pinckney A,et al.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients[J].J Clin Invest,2015,125(8):3285-3296.DOI:10.1172/JCI81722.
[27] Haller MJ,Schatz DA,Skyler JS,et al.Low-dose anti-thymocyte globulin(ATG)preserves β-Cell function and improves HbA1c in new-onset type 1 diabetes[J].Diabetes Care,2018,41(9):1917-1925.DOI:10.2337/dc18-0494.
相似文献/References:
[1]袁扬,孙子林.PANDER与β细胞凋亡[J].国际内分泌代谢杂志,2007,(04):253.
[2]孙敏讷,段宇.老年亚临床甲状腺功能减退症的诊治特点[J].国际内分泌代谢杂志,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
Sun Minne,Duan Yu..Diagnositc and therapeutic characteristics of subclinical hypothyroidism in elderly people[J].International Journal of Endocrinology and Metabolism,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
[3]胡欣 陈国芳 刘超.男性迟发型性腺功能减退症的诊断与治疗[J].国际内分泌代谢杂志,2015,(01):59.[doi:10.3760/cma.j.issn.1673-4157.2015.01.015]
Hu Xin,Chen Guofang,Liu Chao..Diagnosis and therapeutic options for late-onset hypogonadism in men[J].International Journal of Endocrinology and Metabolism,2015,(06):59.[doi:10.3760/cma.j.issn.1673-4157.2015.01.015]
[4]刘媛 刘超.1型糖尿病青少年儿童心理行为问题研究进展[J].国际内分泌代谢杂志,2015,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
Liu Yuan,Liu Chao..Psychological problems in adolescents and children with type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
[5]王思倩,吴锦丹.肠促胰素对1型糖尿病患者血糖及胰岛功能的影响[J].国际内分泌代谢杂志,2015,(03):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
Wang Siqian,Wu Jindan..Effects of incretin on blood glucose and islet function in type 1 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(06):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
[6]李亚兰,项洁,卜瑞芳.1型糖尿病的DiaPep277免疫治疗[J].国际内分泌代谢杂志,2014,(03):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
Li Yalan,Xiang Jie,Bu Ruifang..Immunotherapy with DiaPep277 peptide in type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2014,(06):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
[7]陈晔,李艳玲,王坚.天然免疫细胞在1型糖尿病中的作用[J].国际内分泌代谢杂志,2014,(03):184.[doi:10.3760/cma.j.issn.1673-4157.2014.03.011]
Chen Ye,Li Yanling,Wang Jian..Role of innate immune cells in type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(06):184.[doi:10.3760/cma.j.issn.1673-4157.2014.03.011]
[8]刘晓蓉 朱德发.糖尿病下肢动脉病变的诊断与治疗[J].国际内分泌代谢杂志,2015,(05):327.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
Liu Xiaorong*,Zhu Defa..Diagnosis and treatment of lower extremity arterial disease in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):327.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
[9]蔡芸莹 苏恒.1型糖尿病的非胰岛素治疗[J].国际内分泌代谢杂志,2015,(06):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
Cai Yunying,Su Heng.Noninsulin management in type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
[10]曹琳,刘超.妊娠糖尿病诊疗的争议与共识[J].国际内分泌代谢杂志,2016,36(03):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]
Cao Lin,Liu Chao..Controversy and concensus on the diagnosis and treatment of gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]